Having demonstrated that high levels of ADAM19 mRNA expression correlate with increased disease free survival and lower tumour stage in publicly available prostate cancer microarray databases, we then sought to determine the ADAM19 expression levels in human tumorigenic LNCaP prostate cancer cells and normal RWPE-1 prostate epithelial cells. The gene discussed is ADAM19; the disease is prostate carcinoma.